Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
6.14 USD +2.68% Intraday chart for Vanda Pharmaceuticals Inc. -3.15% +45.50%
20/06 Vanda rejects Future Pak and Cycle Pharma's takeover offers RE
19/06 Cycle Pharmaceuticals Limited cancelled the acquisition of Vanda Pharmaceuticals Inc.. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Vanda rejects Future Pak and Cycle Pharma's takeover offers
RE
Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders
PR
Cycle Pharmaceuticals Limited cancelled the acquisition of Vanda Pharmaceuticals Inc..
CI
Sector Update: Health Care Stocks Ease Late Afternoon
MT
Sector Update: Health Care Stocks Softer Thursday Afternoon
MT
Sector Update: Health Care
MT
Vanda Pharmaceuticals Receives Revised Offer From Future Pak; Shares Rise
MT
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
PR
Future Pak raises cash portion of buyout offer for Vanda
RE
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
BU
Sector Update: Health Care Stocks Higher in Late Afternoon Trading
MT
Sector Update: Health Care Stocks Advance Thursday Afternoon
MT
Sector Update: Health Care
MT
Vanda Pharmaceuticals' Shares Rally After Company Receives $466 Million Buyout Offer From Cycle Pharma
MT
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
PR
Cycle Pharmaceuticals Offers to Buy Vanda Pharmaceuticals for $466 Million
MT
Top Premarket Gainers
MT
Cycle Pharmaceuticals Limited made a proposal to acquire Vanda Pharmaceuticals Inc. for approximately $490 million.
CI
Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US
MT
Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. News Vanda Pharmaceuticals Inc.